Pharma Mar, S.A.
Stock Details
Is it expensive?
Market Cap
1.66B
Trailing P/E Ratio
20.81
Forward P/E Ratio
13.00
PEG Ratio
-0.22
1.52B
21.57
Price-to-Sales (TTM)
7.38
6.69
14.38
Is it profitable?
225.43M
Net Profit Margin (TTM)
35.69%
Gross Profit Margin
91.47%
Diluted EPS (TTM)
4.62
35.99%
Is it growing?
10.40%
-54.37%
Is it risky?
0.41
19.04
47.54M
3.07
Who owns it?
8.37%
29.74%
0.00%
17.31M
13.43M
Does it pay?
3.30%
17.34%
Jun 25, 2025
--
How much cash?
167.85M
68.00M
35.08M
9.67
- Price (EOD)
- 96.15
- Percent Change
- +1.90 (2.02%)
- Previous Close
- 94.25
- Open
- 94.85
- Low
- 94.75
- High
- 99.60
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
€96.15
From 52W Low
+37.16%
From 52W High
-8.60%
Today
+2.02%
1Y Change
+4.62%
6M
€75.50
3M
€80.40
1M
€103.30
Today
€96.15
From 52W Low
+37.16%
From 52W High
-8.60%
Today
+2.02%
1Y Change
+4.62%
6M
€75.50
3M
€80.40
1M
€103.30
Today
€96.15
Above Average
within its 1-year price range
€96.15
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-6.9%
3M
+19.6%
6M
+27.4%
1Y
+4.6%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Above Average
More shares than usual are changing hands today. Above-average volume adds conviction to the current price move, up or down. As reflected in the Relative Volume (RVOL) below.
- Name
- Pharma Mar, S.A.
- Founded
- 1986
- CEO
- Jose Maria Fernandez Sousa-Faro
- Employees
- 505
- Fiscal Year End
- Dec 31, 2025
- Address
Avenida de los Reyes, 1
Madrid
MI
28770
Spain
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.pharmamar.com
Indicators
Operating Cash Flow
68.00M
Net Income
80.47M
Backed by Cash
0.85
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
IBEX Medium CapIndex IBEX Medium Cap - IBEXMC |
Indicators
Operating Cash Flow
68.00M
Net Income
80.47M
Backed by Cash
0.85
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
1.66B
Trailing P/E Ratio
20.81
Forward P/E Ratio
13.00
PEG Ratio
-0.22
1.52B
21.57
Price-to-Sales (TTM)
7.38
6.69
14.38
Is it profitable?
225.43M
Net Profit Margin (TTM)
35.69%
Gross Profit Margin
91.47%
Diluted EPS (TTM)
4.62
35.99%
Is it growing?
10.40%
-54.37%
Is it risky?
0.41
19.04
47.54M
3.07
Who owns it?
8.37%
29.74%
0.00%
17.31M
13.43M
Does it pay?
3.30%
17.34%
Jun 25, 2025
--
How much cash?
167.85M
68.00M
35.08M
9.67
- Price (EOD)
- 96.15
- Percent Change
- +1.90 (2.02%)
- Previous Close
- 94.25
- Open
- 94.85
- Low
- 94.75
- High
- 99.60
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
€96.15
From 52W Low
+37.16%
From 52W High
-8.60%
Today
+2.02%
1Y Change
+4.62%
6M
€75.50
3M
€80.40
1M
€103.30
Today
€96.15
From 52W Low
+37.16%
From 52W High
-8.60%
Today
+2.02%
1Y Change
+4.62%
6M
€75.50
3M
€80.40
1M
€103.30
Today
€96.15
Above Average
within its 1-year price range
€96.15
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-6.9%
3M
+19.6%
6M
+27.4%
1Y
+4.6%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Above Average
More shares than usual are changing hands today. Above-average volume adds conviction to the current price move, up or down. As reflected in the Relative Volume (RVOL) below.
- Name
- Pharma Mar, S.A.
- Founded
- 1986
- CEO
- Jose Maria Fernandez Sousa-Faro
- Employees
- 505
- Fiscal Year End
- Dec 31, 2025
- Address
Avenida de los Reyes, 1
Madrid
MI
28770
Spain
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.pharmamar.com
Related Heatmaps
IBEX Medium CapIndex IBEX Medium Cap - IBEXMC |